Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Holdings
Ownership

UBS Group AG > LYRA

DateNameTickerSharesChangeValueChangePrice
06/30/2023Lyra Therapeutics, Inc.LYRA18-83574,000-1,640,000$4,111.11
03/31/2023Lyra Therapeutics, Inc.LYRA853-2,5441,714,000-8,953,000$2,009.38
12/31/2022Lyra Therapeutics, Inc.LYRA3,39730310,667,00010,652,000$3,140.12
09/30/2022Lyra Therapeutics, Inc.LYRA3,0941,07215,0004,000$4.85
06/30/2022Lyra Therapeutics, Inc.LYRA2,0222,02211,00011,000$5.44
03/31/2022Lyra Therapeutics, Inc.LYRA0-4,0700-18,000 
12/31/2021Lyra Therapeutics, Inc.LYRA4,0704,07018,00018,000$4.42
09/30/2021Lyra Therapeutics, Inc.LYRA0-5670-5,000 
06/30/2021Lyra Therapeutics, Inc.LYRA567-3,0505,000-36,000$8.82
12/31/2020Lyra Therapeutics, Inc.LYRA3,6172,76941,00032,000$11.34
09/30/2020Lyra Therapeutics, Inc.LYRA848-8689,000-10,000$10.61
06/30/2020Lyra Therapeutics, Inc.LYRA1,7161,71619,00019,000$11.07
<< Prev     Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy